Entry created on 1 July 2019 (Revision 1.0) Annotator: Rita Pancsa
Basic protein information
Accession P17931
Common name Galectin-3
Gene LGALS3
Organism Homo sapiens
Uniprot name Galectin-3
Basic LLPS information
Organelle galectin complex; galectin lattice
Type of experimental evidence
Protein region(s) mediating LLPS
20
-
100
Repeats of Y-P-G-X(3)-P-G-A
Based on the experimental results of the following publication: 28893908
Molecular features viewer
PDB structures
Extended LLPS information
Functional description
Galectins are a family of widely expressed β-galactoside-binding lectins in metazoans. The 15 mammalian galectins have either one or two conserved carbohydrate recognition domains (CRDs), with galectin-3 being able to pentamerize; they form complexes that crosslink glycosylated ligands to form a dynamic lattice. The galectin lattice regulates the diffusion, compartmentalization and endocytosis of plasma membrane glycoproteins and glycolipids. The galectin lattice also regulates the selection, activation and arrest of T cells, receptor kinase signaling and the functionality of membrane receptors, including the glucagon receptor, glucose and amino acid transporters, cadherins and integrins (PMID:26092931). Galectin-3 self-associates via inter- and intramolecular NTD–CRD interactions and intermolecular NTD–NTD contacts driven by hydrophobic interactions. Galectin-3 also self-associates when it binds to glycoconjugates, such as those present on the cell surface, resulting in aggregation of these glycoconjugates or the formation of galectin lattices (PMID:28893908). The extracellular domains of transmembrane receptors can be modified with monosaccharides and polysaccharides to create binding sites for the carbohydrate recognition domain of galectin-3. The IDR of galectin-3 self-associates with other IDRs of neighboring galectin-3 molecules to form a multivalent network with modified transmembrane receptors (PMID:30951647).
Literature supporting the LLPS: 28893908, 30951647, 26092931
Functional class of membraneless organelle: biomolecular filter/selectivity barrier
Binding partners (at biological protein concentrations)
1) glycoconjugated extracellular domains of transmembrane receptors
Type of RNA(s) required/used for the LLPS at biological protein concentrations
RNA not required.
Molecular interaction types contributing to LLPS
discrete oligomerization (PMID:26092931) simple coacervation of hydrophobic residues (PMID:28893908)
Determinants of phase separation and droplet properties
1) protein concentration of galectin-3 2) temperature 3) salt concentration
Membrane cluster Yes
Partner-dependent No
RNA-dependent No
PTM required No
Domain-motif interactions No
Discrete oligomerization Yes
Regulation and disease
Post-translational modifications affecting LLPS
Position Residue PTM Effect Reference Modifying enzyme Notes
Isoforms known to affect LLPS
Isoform Effect Reference
All known isoforms containing sequence changes in the LLPS region(s)
Position type Isoform names from UniProt
Disease mutations affecting LLPS
Mutation dbSNP Disease OMIM Effect Reference Notes
Experimental information
Experimental techniques applied to prove/investigate LLPS
Galectin-3 self-associates via inter- and intramolecular NTD–CRD interactions and intermolecular NTD–NTD contacts (physical interaction) driven by hydrophobic interactions as demonstrated by NMR in vitro. These interactions are sensitive to change in salt concentration. In high concentration, the N-terminal domain of galectin-3 undergoes LLPS in a temperature-dependent, reversible manner as assessed by observing the change in optical properties (tubidity) of the sample. Liquid droplets were obderved by microscopy, and their observed fusion events further support their liquid-like property (morphology). PMID:28893908.
Experimental observations supporting the liquid material state of the condensate
temperature-dependence (PMID:28893908) reversibility of formation and dissolution (PMID:28893908) morphological traits (PMID:28893908)